BioengineeringbioRxivPreprint
Recombinant annexin A6 promotes membrane repair in a stem cell derived-cardiomyocyte model of dystrophic cardiomyopathy
D. E. Fullenkamp, A. B. Willis, J. L. Curtin…·E. M. McNally
The paper demonstrates that recombinant annexin A6 reduces membrane damage in DMD iPSC-CMs under mechanical stress, showing potential therapeutic efficacy for DMD-related cardiomyopathy.
DOI 10.1101/2022.03.09.483528